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objectives. This study was designed to compare the influence of 
beta-adrenergic stimulation (dobutnmine) and a selective phos- 
phodiesterase inhibitor (MS-g571 on left ventricular diastolic 
performance and Doppler transmitral flow velocity patterns in 
patients with congestive heart failure and to elucidate the mech- 
anisms for changes in early diastolic filling induced by each agent. 
Bu&w&. Both beta-adrenergic agonists and phosphodies- 
tense inhibitors act through the cyclic adenosine monophosphate 
pathway. However, it is controversial whether they have similar 
effects on diastolic performance. No previous studies have inves- 
tigated the effects of these agents on Doppler-derived measure- 
ments of diastolic filliag. \ Ye hvpothesized that they would have I 
different effects on early diastolic filling in patients with congestive 
heart failure. 
Methods. Twenty patients with chronic congestive heart failure 
resulting from idiopathic dilated cardiomyopathy were random- 
ized to receive intravenous infusion of dobutamine (5 &kg body 
weight per min, n = 10) or oral administration of MS-857 (15 mg, 
n = 10). Transmitral flow velocity patterns were obtained with 
simultaneous recordings of pressure-volume loops using a con- 
Doppler echocardiography provides a useful noninvasive tech- 
nique for evaluating left ventricular filling dynamics on a 
beat-to-beat basis (1). Left ventricular diastolic filling is influ- 
enced not only by the processes of active relaxation and the 
passive elastic properties of the lef& ventricle, but also by left 
atria1 pressure, left atria1 compliance, mitral impedance and 
left ventricular systolic function (1). The passive elastic prop- 
erties are assessed by analyzing the diastolic pressure-volume 
relation of the left ventricle. It is known that left ventricular 
relaxation, ventricular interaction modulated by the pericar- 
dium, elastic recoil (diastolic suction), pulmonary-cardiac con- 
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ductance catheter with a micromanometer tip before and after 
drug administration. 
Results. f&t ventricular filling pressure was reduced by both 
agents. Dobutamine decreased the time constant of isovolumetric 
relaxation and increased the difference between pulmonary artery 
wedge pressure at the peak of the v wave and left ventricular 
minimal pressure (10 f 3 to 12 f 4 mm Hg, p < 0.01) and peak 
early filling velocity (47 * 7 to 56 i: 11 cm/s, p 6 0.01). The 
diastolic pressure-volume relation showed a leftward shift in all 
patients. In contrast, MS-857 did not affect the time constant but 
maintained the pressure difference (9 + 3 to 8 f 3 mm Hg, p = 
NS) and peak early filling velocity (50 f 7 to 49 2 12 cm/s, p = 
NS). The diastolic pressure-volume relation after MS-857 showed 
a downward shift in most patients. 
Couclusions. These results indicate that beta-adrenergic stim- 
ulation and phosphodiesterase inhibitors have different effects on 
early diastolic filling through different mechanisms in patients 
with congestive heart failure. 
(J Am Co11 Cardiol1995;25:295-304) 
_._-_... - _.... 
tact pressure, viscoelastic properties of the myocardium and 
coronary vascular engorgement all play some role in determin- 
ing the diastolic pressure-volume relation (2). Therefore, it is 
useful to evaluate shifts in the diastolic pressure-volume 
relation when interpreting changes in left ventricular diastolic 
filling induced by immediate pharmacologic interventions. 
Both beta-adrenergic agonists (3,4) and phosphodiesterase 
inhibitors (5,6) are the major inotropes available for treating 
congestive heart failure. They enhance left ventricular systolic 
performance by increasing intracellular levels of cyclic adeno- 
sine monophosphate (cyclic AMP) in cardiac myocytes (7-9) 
However, there are some controversies as to whether they have 
similar effects on diastolic performance. Beta-adrenergic stim- 
ulation has been shown to produce a positive lusitropic effect 
in both normal subjects and in patients with congestive heart 
failure (10). Some investigators (56) have also demonstrated 
an improvement in relaxation variables with phosphodiester- 
ase inhibitors in patients with congestive heart failure. How- 
ever, others reported ditferent effects of these two types of 
inotropes on diastolic performance in clinical (11) and exper- 
imental (12) studies. No previous studies have compared the 
effects of these agents on left ventricular filling dynamics as 
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assessed by Doppler echocardiography. We hypothesized that 
heia-adrenergic stimulation and phosphodiesterase inhibitors 
would have different effects on early diastolic filling in patients 
with congestive heart failure. To test this hypothesis, we 
evaluated the influence of dobut.*-; ,~~,ne and a selective phos- 
phodiesterase inhibitor, MS-857, on diastolic performance and 
Doppler transmitral flow velocity patterns in patients with 
dilated cardiomyopathy, and explored the mechanisms under- 
lying changes in early diastolic filling induced by each agent. 
MS-857, 4-acetyi-l-methyi-7-(4-pyridyl)-5,6,7,8-tetrahydro- 
3(2!f)-isoquinolinone, is a new orally active cardiotonic agent 
that exerts both positive inotropic and direct vasodiiator effects 
by selectively inhibiting phosphodiesterase isozyme III but 
does not modify the sensitivity of the contractile apparatus to 
calcium (13-15). 
Methods 
Study patients. Twenty patients with chronic congestive 
heart failure resulting from idiopathic dilated cardiomyopathy 
were studied (17 men, 3 women; mean age 55 years. range 37 
to 65). All patients were in normal sinus rhythm. Idiopathic 
dilated cardiomyopathy was defined as a decrease in left 
ventricular ejection fraction to <50%, as determined by con- 
trast ventricuiography, and a dilated left ventricular cavity in 
the absence of significant coronary artery disease, structural 
mitral valve disease, systemic hypertension, pericardial disease 
or myocardial disease caused by any known systemic disease. 
Patients with significant regional wall motion abnormalities or 
severe mitral regurgitation were excluded from the study. 
Mitral regurgitation was assessed semiquantitatively (grade 1 
to 4) by contrast ventricuiography as grade 1 in seven patients 
and grade 2 in four patients and was absent in the other nine 
patients. All patients had experienced symptomatic heart 
failure despite therapy with digoxin and diuretic agents and 
complained of dyspnea at rest or on exertion. At the time of 
the study, they had New York Heart Association functional 
class II or ill congestive heart failure. 
Protocol. Right and left heart catheterization were per- 
formed by the femoral approach in fasting patients. All 
medications were withheld for at least 48 h before catheteriza- 
tion. A 7F Swan-Ganz catheter (Goodtec) was advanced to the 
pulmonary artery wedge position under fluoroscopic and he- 
modynamic guidance. Cardiac output was obtained by the 
thermodilution technique. A 5F pigtail catheter was placed in 
the proximal aorta to measure aortic pressure. After contrast 
ventriculography was performed, an 8F volume conductance 
catheter (Leycom) with a 2F micromanometer-tipped catheter 
(Millar) was positioned into the left ventricular apex to obtain 
left ventricular pressure-volume loops (16). An 8F Fogarty 
catheter (Baxter) was placed in the inferior vena cava and was 
inflated transiently to determine the left ventricular end- 
systolic pressure-volume relation (17). 
Hemodynamic measurements, left ventricular pressure- 
volume loops and Doppler transmitral flow velocity patterns 
were obtained at baseline study. After baseline data were 
Table 1. @emographic Data for Study Patients According to 
Drug Assignment 
Dohutaminc MS-E57 
(n = IO) (n = IO) 
4s (yr! 55 i_ 7 56 -c s 
Male gender 8 (80%) i) (s&i,;;) 
NYHA functional class 
II 5 (502) 4 (40%) 
111 5 (50%) 6 (60’1, ) 
Severity of MR 
None 4 (40%) 5 (50%) 
Grade 1 4 (40%) 3 (30%) 
Grade 2 2 (20%) 2 (20%) 
LVEDVI (ml/m’) 154 f 21 158 i 23 
LVEF (‘ZJ) 30 t 8 2s 2 10 
Data presented are mean value + SD or number (7%) of patients. LVEDVI = 
left ventricular end-diastolic volume index; LVEF = left ventricular ejection 
fraction; MR = mitral regurgitation: NYHA = New York Heart Association. 
recorded, patients were randomized to receive dobutamine 
infused at a rate of 5 &kg body weight per min (n = 10) or 
MS-857, a phosphodiesterase inhibitor, in a single oral dose of 
15 mg (n = 10). Table 1 shows the demographic data for the 20 
patients according to drug assignment, and the groups were 
comparable. Measurements were again obtained when the 
hemodynamic indexes were stabilized 15 min after initiation of 
the continuous infusion of dobutamine or 45 min after oral 
administration of MS-857. This study protocol was reviewed 
and approved lly the institutional committee on human inves- 
tigations. Each patient gave written informed consent for study 
participation. 
Hemodynamic measurements. Routine hemodynamic 
measurements were obtained. The difference between pulmo- 
nary artery wedge pressure at the peak of the v wave and left 
ventricular minimal pressure was used as an index of early 
diastolic transmitrai pressure gradient. Pulmonary artery 
wedge pressure at ih,: peak of the v wave was chosen because 
it occurs at or near the time of mitral valve opening. In so 
doing, we took into account the delay between pressure 
transients measured by pulmonary artery wedge catheter and 
those measured in left atrium. This method did not allow 
measurement of instantaneous transmitral pressure gradient 
throughout filling but provided an index of maximal early 
diastolic transmitral pressure gradient at mitral valve opening. 
The time constant of isovolumetric relaxation was calculated 
from the logarithmic method of Weiss et al. (for TL) (18) and 
from the derivati-ge method of Raff and Glantz (19) (for TD). 
Pressure-volume analysis. An 8F volume conductance 
catheter (Leycom) was advanced to the left ventricular apex 
under fluoroscopic guidance. An externally balanced and cal- 
ibrated 2F micromanometer-tipped catheter (Millar) was in- 
serted into the left ventricle through a lumen of the conduc- 
tance catheter. The conductance catheter was connected to a 
volumetric system (model Sigma 5) to measure left ventricular 
conductance and convert it to left ventricular volume. Real 
time pressure-volume diagram generation and eight-channel 
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Tsbllc 2. i3kct~ of Doburamine and MS-857 on Hemodynamic and Doppler Indexes 
Basclinc Dobutaminc Baseline MS-857 
HR (hcats!min! 
MAP (mm Hg) 
Cl (litersimin per m’) 
SYI (ml/m’) 
PAWP (mm Hg) 
RAP (mm Hg) 
LVPSP (mm Hg) 
LVPmin (mm Hg) 
LVEDP (mm Hg) 
VwaveWP (mm Hg) 
VwaveWP - LVPmin (mm Hg) 
+dP/dt (mm Hgis) 
-dP/dt (mm Hgls) 
TL (ms) 
To (ms) 
LVEDVI (ml/m‘) 
LVESVl (ml!m2) 
LVEF (%) 
Ecs (mm Hgimi) 
E (cm/s) 
A (cm/s) 
E/A ratio 
IVRT (ms) 
73 _c 9 
91 z IO 
1 6 f. 0.6 
36 ” 6 
lx?4 
xi2 
I.36 2 20 
11 52 
1954 
?O 2 5 
10 z 3 
1,008 2 282 
1.081 -t 195 
582 8 
69 5 8 
l54f21 
107 i 16 
302 8 
0.85 i 0.30 
47 i 7 
54 i 9 
0.90 3 0.22 
9027 
19 2 Y 
YY 2 I? 
3.7 2 1.0” 
46 r 0” 
15 rt 3* 
722 
14c 2 22” 
5 2 26 
16 I3* 
1714* 
12-r4* 
1.593 c475* 
I.578 t409* 
40 +x* 
52 2 9* 
137 It 20* 
85 i 15* 
38 t 9* 
1.38 2 0.30* 
56 t 11* 
61 i 8* 
0.93 ? 0.24 
71 i 8' 
73-r I- 
YS + 16 
2.3 2 0.4 
35 z 0 
id + 3 
xi3 
13.5 ? 24 
10 t 2 
20 _f 4 
1924 
9?3 
1,039 ? 296 
1,048 + 302 
53 2 3 
63 i 10 
158 2 23 
113 2 21 
28~ 10 
0.86 i 0.33 
5027 
53 -c 7 
0.96 2 0.26 
901?-7 
71? i?i 
01 -_ 1.w 
3.tJ Z O..s+$ 
4128~ 
12 + 3ti: 
5 Ir2if 
131~ 23t 
6 + 2$ 
13 t4t.t 
13 "41$ 
8231 
1,095 %305t$ 
1.038 2262-f 
51r7t 
62 2 lit 
I<4 i 237 
100 f 26-f9 
3s f 12$ 
1.21 + 0.44$ 
492 12t 
67i6tS 
0.76 c 0.24iS 
102 -t 11ti 
*p < 0.01, dobutamine versils baseline. tp < 0.01, $p < 0.05. MS-857 versus dobutamine. fp < 0.01, MS-857 versus 
baseline. Data presented are mean value 2 SD. A(E) = peak late (early) filling velocity; CI = cardiac index: +dP/dt 
(-dP/dt) = peak positive (negative) first derivative of left ventricular pressure; Ees = left ventricular end-systolic 
eiastance; HR = heart rate: IVRT = isovolumetric relaxation time; LVEDP = left ventricular enddiastolic pressure; 
LVESVI = left ventricular end-systc4ic volume index; LVPmin = left ventricular minimal pressure; LVPSP = left 
ventricular peak systolic pressure; MAP = mean aortic pressure; PAWP = mean pulmonary artery wedge pressure; 
RAP = mean right atrial ppessure; SV1 = stroke volume index; TD (TL) = time constant of isovolumetric relaxation 
derived from the derivative (!ogarithnic) method; VwaveWP = pulmonary artery wedge pressure at the peak of the t 
wave; other abbreviations as in Table 1. 
analog/digital conversion (at 200 Hz) were performed by using a 
16-bit microcomputer system (PC-98OlVX, NEC Co., Tokyo, 
Japan). The pressure-volume data were obtained during end- 
rxpiratoly apnea to minimize respiratory variation. Th,: ventric- 
ular volume obtained by the conductance method was calibrated 
by contrast ventriculography, as described in our previous study 
(20). An end-systolic pressure-volume lime was drawn on the left 
upper comers of the pressure-volume loops obtained during 
transient caval occlusion. The slope of the end-systolic pressure- 
volume relation, or left ventricular end-systolic elastance, was 
determined by linear regression analysis (21). 
Doppler echocardiographic examination. Pulsed-wave 
Doppler echocardiograms were obtained with an Acuson 
model 128XP/lO imaging system with a 2.5-MHz transducer. 
Flow velocity signals, electrocardiograms and phonocardio- 
grams were recorded on a strip chart at a paper speed of 
100 mm/s. Patients were examined in the supine position. 
During imaging in the apical four-chamber view, the sample 
volume was placed at the level of the mitral annulus. The 
angle between the interrogating beam and the apparent 
direction of blood flow was judged to be ~20” in all 
instances, and no correction factor was used. The Doppler 
data were obtained simultaneously with the pressure- 
volume data during end-expiratory apnea. Peak early filling 
velocity, peak late filling velocity, peak early/late filling 
velocity ratio and isovolumetric relaxation time were mea- 
sured before and after drug administration. Isovolumetric 
relaxation time was calculated as the time interval from 
aortic valve closure (first high frequency component of the 
second heart sound) to mitral valve opening (onset of 
transmitral flow). A microcomputer-assisted planimeter (X- 
PLAN360i, Ushikata, Tokyo, Japan) was used to measure 
flow velocities and time intervals, All values were deter- 
mined as the mean of 3 to 5 bears. Doppler echocardio- 
graphic recordings were analyzed and measured by an 
observer who was unaware of the patient’s status. 
Statistical analysis. Data presented in the tables are mean 
value t SD. Data before and after drug administration within 
a single group were compared by means of a paired t test. Data 
between groups were compared by means of an unpaired t test 
and analysis of variance. Correlations between Doppler echo- 
cardiographic and hemodynamic indexes were determined by 
simple least-squares liuear regression analysis. A p value ~0.05 
was considered statistically significant. 
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Figure 1. Effects of dobutamine and MS-857 on mean 
pulmonary artery wedge pressure (PAWP) and peak 
early filling velocity (E). Although mean pulmonary 
artery wedge pressure decreased with bm’l agents, peak 
early filling velocity was increased by dobutamine, 
whereas it was maintained by MS-857. 
we post we post 
dobutamine MS-857 
Results 
There were no significant differences between the two 
groups in any of the measured or derived variables at baseline 
study (Table 2). 
Efects of dobutamine on bemodyuamic and Doppler in- 
dexes. Mean pulmonary artery wedge pressure and pulmonary 
artery wedge pressure at the peak of the v wave decreased 
significantly with dobutamine (Table 2, Fig. 1 [upper panel]). 
There was a significant increase in left ventricular peak nega- 
tive first derivative of left ventricular pressure (dP/dt) and a 
significant reduction in the time constant of isovolumetric 
relaxation (both TL and TD). Dobutamine produced a signifi- 
cant reduction in left ventricular minimal pressure and a 
significant increase in the difference between pulmonary artery 
wedge pressure at the peak of the v wave and left ventricular 
minimal pressure. Dobutamine caused a concomitant decrease 
in left ventricular end-diastolic pressure and volume and a 
significar i reduction in left ventricular end-systolic volume 
with a resultant increase in left ventricular ejection fraction. 
There was an increase in left ventricular end-systolic elastance, 
left ventricular peak positive dP/dt, mean aortic pressure, left 
ventricular peak systolic pressure, cardiac index, stroke volume 
index and heart rate. Mean right atria1 pressure was un- 
changed. After dobutamine, the diastolic pressure-volume 
relation shifted lefhvard along an apparently unchanged dia- 
stolic pressure-volume curve in all patients (Fig. 2). Dobut- 
amine produced a significant increase in peak early filling 
velocity (Fig. 1, upper panel). Peak late filling velocity was also 
increased, but there was no change in penk early/late filling 
velocity ratio. Isovolumetric relaxation time was shortened 
significantly. A representative pair of Doppler transmitral flow 
velocity patterns before and after dobutamine administration 
are shown in Figure 3 (upper panel). 
Effects of MS-857 on hemodynamic and Doppler indexes. 
MS-857 produced a significant decrease in mean pulmonary 
artery wedge pressure and pulmonary artery wedge pressure at 
299 vAGAT.4 ET AL. 
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the peak of v wave (Table 2, Figure 1 [lower panel]). MS-857 
did not affect the time constant (neither TL nor TD) 01 left 
ventricular peak negative dP/dt, but there was a significant 
decrease in left ventricular minimal pressure. The difference 
between pulmonary artery wedge pressure at the peak of the r 
wave and left ventricular minimal pressure was unaltered. 
Although left ventricular end-diastolic volume remained un- 
changed, there was a significant reduction in left ventricular 
end-diastolic pressure. MS-857 caused a decrease in left ven- 
tricular end-systolic volume and an increase in left ventricular 
ejection fraction. Left ventricular end-systolic elastance, left 
ventricular peak positive dP/dt, cardiac index and stroke 
volume index increased significantly. Mean aortic pressure and 
left ventricular peak systolic pressure decreased not signifi- 
cantly but slightly. Heart rate was unchanged. Mean right atria1 
pressure decreased significantly. MS-857 produced a down- 
ward shift of the diastolic pressure-volume relation in 8 of 10 
patients (Patients 2 to 8 and 10). In the remaining hKo patients 
(Patients 1 and 9), the diastolic pressure-volume relation 
shifted leftward after MS-857 (Fig. 4). IMS-857 produced no 
change in peak early filling velocity (Fig. 1, lower panel) and an 
increase in peak late filling velocity, resulting in a decrease in 
peak early/late filling velocity ratio. Isovolnmetric relaxation 
time decreased significantly. A representative pair of Doppler 
transmitral flow velocity patterns before and after MS-857 
administration are shown in Figure 3 (lower panel). 
Figure 2. Effects of dobutamine on the diastolic pressure-volume 
relation. Dobutamine resulted in a decrease in left ventricular end- 
diastolic pressure with a concomitant decrease in left ventricular 
end-diastolic volume. In all patients, dobutamine produced a leftward 
shift of the dias,otic pressure-volume r lation along a single pressure- 
voiume curve, achieving lower left ventricular minimal pressure. Solid 
line = before dobU!amine; dashed line = after dobutanine. No. 1 to 
No. 10 = Patients 1 to 10. 
Comparison of the effects of dobutamine and MS-857 
shows that there was a greater decrease in left ventricular 
end-systolic volume with dobutamine than that with MS-857 
(p < 0.05). The increase in left ventricular end-systolic elas- 
tance with dobutamine was greater than that with MS-857, but 
the difference was not statistically significant (p = 0.09). The 
increase .J cardiac index was greater with dobutamine than 
that with MS-857 (p < 0.05), but there was no difference in the 
increase in stroke volume index. 
Correlation between hemodynamic and Doppler indexes. 
In all patients, changes in peak early tilling velocity correlated 
directly with changes in mean pulmonary artery wedge pres- 
sure (r = 0.64, p 4 0.01) and pulmonary artery wedge pressure 
at the peak of the v wave (r = 0.65, p < 0.01) (Fig. 5, left 
panel). There was a better correlation between changes in peak 
early filling velocity and in the difference between pulmonary 
artery wedge pressure at the peak of the v wave and left 
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Figure 3. Representative changes in Dopp 
ler transmitral flow velocity patterns with 
dobutamine (upper panel) and MS-857 
(lower panel). ECG = electrocardiogram; 
I CG = phonocardiogram. Peak early (E) 
filling velocity increased with dobutamine, 
whereas it was unchanged by MS-857. A = 
atria1 flow velocity. 
60 
40 
20 
0 i 
--I ^ --. - ‘-..-.- 
k 
500 msoc -I 
ventricular minimal pressure (r = 0.93, p < 0.01) (Fig. 5. right 
panel). Changes in peak early filling velocity did not correlate 
with changes in left ventricular end-systolic elastance or in the 
time constant. 
Discussion 
In the present study, we demonstrated that two different 
inotropes, dobutamine and a selective phosphodiesterase in- 
hibitor (MS-857) have different effects on Doppler-derived 
measurements of early filling dynatnks through different 
mechanisms in patients with congestive heart failure. 
Influence of left ventricular relaxation on early diastolic 
filling. The rate of re!axation is important for determining left 
ventricular minimal pressure and producing an explosive filling 
of the left ventricle in early diastole (2). When relaxation is 
impaired, left ventricular filling is dependent on vigorous atria1 
contraction (22). If left atria1 contraction is absent or inade- 
quate, left ventricular filling requires an elevated mean left 
atria1 pressure. Because it is an increase in mean left atria1 
pressure (not left ventricular end-diastolic pressure itself) that 
produces pulmonary congestion (23) changes in the rate of 
relaxation have a clinically important infuence on overall !eft 
ventricular diastolic performance. The extent of systolic short- 
ening affects the rate of relaxation (18). In our patients, 
dobutamine caused a concomitant decrease in left ventricular 
end-diastolic pressure and volume, resulting in a leftward shift 
of the diastolic pressure-volume relation along a single dia- 
stolic pressure-volume curve. Left ventricular end-systclic vol- 
ume was reduced by dobutamine to a greater extent than by 
MS-857. Dobutamine increased left ventricular peak negative 
dP/dt and reduced the time constant of isovolumetric relax- 
ation substantially. Therefore, an improvement in relaxation 
with dobutzmine appears to be largely mediated by increased 
systolic shortening with enhancement of inkrnal restoring 
forces. 
The relaxation rate has been shown to be affected by 
inotropic state and after!oad (24,25). Both beta-adrenergic 
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agonists and phosphodiesterase inhibitors exert positive ino- 
tropic effects by increasing intracellular levels of cychc AMP in 
myocytes and thereby Laeasing systolic calcium availability by 
increasing calcium entry through the salcolemmal calcium 
channel (7-9). Beta-adrenergic agonists have a positive !usi- 
tropic action that is caused by increasing the rate of sarcoplas- 
mic reticular calcium reuptake by a phospholamban-mediated 
mechanism as well as decreasing the calcium sensitivity of 
troponin C (7). In contrast, alterations in diastolic perfor- 
mance seen with phosphodiesterase inhibitors differ little from 
those of the vasodilator nitroprusside (11). In most of the 
previous studies demonstrating an improvement in relaxation 
variables with phosphodiesterase inhibitors, there had been 
observed a decrease in afterload (5,6). In our study, MS-857 
produced an increase in left ventricular end-systolic elastance 
as a load-independent index of contractility, and not signifi- 
cantly but a slight decrease in mean aortic pressure and left 
ventricular peak systolic pressure as measures of afterload, but 
there was no reduction in the time constant. The mechanism of 
this finding is unknown. 
Influence UC ventricular interaction and pericardial con- 
straint on early diastolic filling. The diastolic pressure- 
voiume relation is influenced by the external mechanical 
environment of the left ventricle, in particular, the right 
ventricle and the pericardium (26,27). The vasodilator nitro- 
prusside has been shown to produce a downward shift of the 
Figure 4, Effects of MS-857 on the diastolic pressure-volume relation. 
MS-857 decreased left ventricular end-diastolic pressure substantially 
with no or minimal decrease in left ventricular end-diastolic volume. In 
8 of 10 patients (Patients 2 to S and lo), MS-857 produced a downward 
shift of the diastolic pressure-volume relation. In only two patients 
(Patients 1 and 9) did the diastolic pressure-volume relation show a 
ieftward rather than a downward shift after MS-857. A downward shift 
of the diastolic pressure-volume relation contributes to a decrease in 
ieft ventricular minimal pressure. Solid line = before MS-857; dashed 
line = after MS-857. No. 1 to No. 10 = Patients 1 to 10. 
diastolic pressure-volume relation (27). This downward shift 
may also contribute to a reduction in left ventricular minimal 
pressure and, therefore, a preservation of early diastolic filling. 
The phosphodies:erase inhibitor MS-857 has been shown to 
have vasodilator in addition to positive inotropic actions (15). 
In this study, MS-857 maintained peak early filling velocity 
despite a decrease in left ventricular filling pressure and no 
improvement in relaxation. MS-857 was associated with a 
downward shift of the diastolic pressure-volume relation in 8 of 
10 patients and a leftward shift in only 2 patients. When inertial 
and viscous effects for a moment are neg!igible at end-diastole, 
left ventricular end-diastolic pressure is balanced by the sum of 
left ventricular end-diastolic transmural pressure (true left 
ventricular preload) and extraventricular pressure (pericardial 
pressure). Our results suggest that there was no or minimal 
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Figure 5. Changes in peak early filling velocity (AE) plotted as a 
function of changes in pulmonary artery wedge pressure at the peak of 
the v wave (AVwaveWP) (left) and those in the difference between 
pulmonary artery wedge pressure at the peak of the v wave and left 
ventricular minimal pressure (AVwaveWP - LVPmin) (right). 
Changes in peak early filling velocity correlated much better with 
changes in the difference between pulmonary artery wedge pressure at 
the peak of the v wave and left ventricular minimal pressure (r = 0.93, 
p < 0.01) than with those in pulmonary artery wedge pressure at the 
peak of the v wave (r = 0.65, p < 0.01). Open circles = dobutamine; 
closed circles = MS-857. 
change in left ventricular end-diastolic transmural pressure 
with MS-857 and that the decrease in left ventricular end- 
diastolic pressure was mainly due to the decrease in extraven- 
kricular pressure. Right atria1 pressure has been proposed as a 
surrogate for direct measurement of pericardial pressure (27). 
Baseline right atria1 pressures in the eight patients who had a 
downward shift of the diastoiic pressure-volume relation (av- 
erage 9 mm Hg, range 6 to 13) were higher than those in the 
two patients who had a leftward shift (3 and 6 mm Hg). This 
finding suggests that ventricular interaction modulated by the 
pericardium may play some ro!e in determining the predrug 
diastolic pressure-volume relation. 
Influence of heart rate on early diastolic filling. Although 
Weiss et al. (18) reported that heart rate had only a slight 
influence on the time constant, subsequent studies in animal 
models (19,25,28) and in humans (29) have suggested that the 
time constant decreases with increased heart rate. It has been 
also demonstrated (29) that left ventricular minimal pressure 
correlates with the time constant during atria1 pacing tachycar- 
dia as well as at rest heart rate. In addition, data from Freeman 
ti:t al. (28) indicated a close relation between heart rate and 
end-systolic elastance. In our study, MS-857 did not affect 
heart rate, whereas dobutamine produced a 10% increase in 
heart rate in association with decreases in TL by 32% and in TD 
by 24%. Therefore, it is possible that an increase in heart rate 
after dobutamine administration may have affected the time 
constant, left ventricular minimal pressure, end-systolic elas- 
tance and peak early filling velocity. However, this possibility 
may not affect the conclusions of this study because changes in 
peak early filling velocity with increased heart rate are not 
considered to be related to changes in diastolic filling period 
but to hemodynamic changes associated with such altera?irJns 
in heart rate. Feldman et al. (30) found no changes in the time 
constant, end-systolic pressure-volume ratio or peak filling rate 
during atria1 pacing tachycardia in patients with dilated car- 
diomyopathy. It is therefore unlikely that an increase in heart 
rate would be largely responsible for the improvements in 
hemodynamic and Doppler indices observed after dobutamine 
administration. 
Isovolumetric relaxation time. Because isovolumetric re- 
laxation time is measured as the time interval from aortic valve 
closure to mitral valve opening, it is affected by determinants of 
the valve movements. Therefore, isovolumetric relaxation time 
is influenced by end-systolic aortic pressure and left atria1 
pressure as well as the rate of relaxation. In our study, 
dobutamine was associated with a decrease in isovolumetric 
relaxation time despite a decrease in left ventricular filling 
pressure and an increase in aortic pressure, indicating that 
isovolumetric relaxation time was more affected by an increase 
in the rate of relaxation. In cont:.:st, MS-857 produced an 
increase in isovolumetric relaxation time with no significant 
changes in aortic pressure or the time constant. This might be 
largely due to a reduction in left ventricular filling pressure. 
Limitations of the study. We used fluid-tiled catheter 
measurements of pulmonary artery wedge pressure as a surro- 
gate for left atria1 pressure because direct transseptal measure- 
ments were not considered to be ethically justified. direct high 
fidelity measurements of left atrial pressure may have been 
associated with better correlations between hemodynamic and 
Doppler indexes. However, our previous study (31) has dem- 
onstrated a good correlation between the difference between 
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pulmonary artery wedge pressblc d:! the peak of the v wave References 
and left ventricular minimal pressure and peak early filling 
velocity. 
/&itOiigi? p&n+ ,S with se\ierr mitral regurgitatic:n wcrc 
e;;cluded from the study, some of the patients receiving 
dobatamire or MS-857 had mild to moderate mitral regurgi- 
tation at baseline study. Mitral regurgitation often substantially 
modifies Dopn!er transmitral flow velocity patterns in dilated 
cardiomyopathy (32). The severity of mitral regurgitation, 
which can be altered by changes in loading conditions with 
drug administration, was not evaluated in our study. However, 
no patients had giant v waves throughout the study, and there 
were no differences in the hemodynamic responses to drug 
administration between those witn and without mitral regurgi- 
tation. 
We did not make a dtrect me’, s!!rivwni of ~>cricar~lial 
pressure. It has been shown that thci~ 1~ J c.Josc relation 
between right atria1 pressure and pericardial pressure (27). 
However, it is unknown whether this relation is also present in 
patients WI’? dilated cardiomyopathy (33). In our study, the 
magnitude of changes in right atrial pressure with MS-857 was 
not necessarily reiated to the magnitude of shifts in the 
diastolic pressure-volume relation. Accordingly, there may be 
some limitation for the usefulness of right atria1 pressure as an 
indirect estimate of extraventricular pressure. 
Clinical implications. The results of this study imply that 
beta-adrenergic agonists and phosphodiesterase inhibitors 
have different effects on early filling dynamics through differem 
mechanisms in patients with congestive heart failure. Because 
the left ventricle fills under the action of the left atria1 to left 
ventricular pressure gradient, left ventricular minimal pressure 
affects early diastolic filling. A key determinant of left ventric- 
ular minimal pressure is left ventricular relaxation, elastic 
recoil (diastolic suction), ventricular interaction and pericar- 
dial constraint. Because the significance of elastic recoil has 
not been established in the dilated left ventricle, the role of 
elastic recoil may be small in the present study. A leftward shift 
of the diastolic pressure-volume relation with beta-adrenergic 
agonists is associated with an increase in the rate of relaxation 
and a decrease in left ventricular minimal pressure, leading to 
more rapid early diastolic filling despite a reduction in left 
ventricular filling pressure. A downward shift of the diastolic 
pressure-volume relation with phospbodiesterase inhibitors, 
related to relief of extrinsic compression of the distended left 
ventricle by the right ventricle and the pericardium, contrib- 
utes to a reduction in left ventricular minimal pressure and 
therefore to preservation of early diastolic filling despite a 
reduction in left ventricular filling pressure and no improve- 
ment in relaxation. 
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